These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

12413 related items for PubMed ID: 11296616

  • 1. Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts.
    Gabius HJ, Darro F, Remmelink M, André S, Kopitz J, Danguy A, Gabius S, Salmon I, Kiss R.
    Cancer Invest; 2001; 19(2):114-26. PubMed ID: 11296616
    [Abstract] [Full Text] [Related]

  • 2. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
    Galanina OE, Kaltner H, Khraltsova LS, Bovin NV, Gabius HJ.
    J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830
    [Abstract] [Full Text] [Related]

  • 3. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
    Gabius HJ, Gabius S, Joshi SS, Koch B, Schroeder M, Manzke WM, Westerhausen M.
    Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410
    [Abstract] [Full Text] [Related]

  • 4. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
    Kunze E, Schulz H, Adamek M, Gabius HJ.
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
    [Abstract] [Full Text] [Related]

  • 5. Probing the cons and pros of lectin-induced immunomodulation: case studies for the mistletoe lectin and galectin-1.
    Gabius HJ.
    Biochimie; 2001 Jul; 83(7):659-66. PubMed ID: 11522395
    [Abstract] [Full Text] [Related]

  • 6. Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro.
    Hostanska K, Hajto T, Fischer J, Mengs U, Weber K, Lentzen H, Saller R.
    Cancer Detect Prev; 1999 Jul; 23(6):511-23. PubMed ID: 10571662
    [Abstract] [Full Text] [Related]

  • 7. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
    Kunze E, Schulz H, Gabius HJ.
    J Cancer Res Clin Oncol; 1998 Jul; 124(2):73-87. PubMed ID: 9654190
    [Abstract] [Full Text] [Related]

  • 8. Clinical relevance of immunoactive mistletoe lectin-I.
    Beuth J.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
    [Abstract] [Full Text] [Related]

  • 9. The immunomodulatory beta-galactoside-specific lectin from mistletoe: partial sequence analysis, cell and tissue binding, and impact on intracellular biosignalling of monocytic leukemia cells.
    Gabius HJ, Walzel H, Joshi SS, Kruip J, Kojima S, Gerke V, Kratzin H, Gabius S.
    Anticancer Res; 1992 Apr; 12(3):669-75. PubMed ID: 1622124
    [Abstract] [Full Text] [Related]

  • 10. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.
    Hajto T, Hostanska K, Gabius HJ.
    Cancer Res; 1989 Sep 01; 49(17):4803-8. PubMed ID: 2758413
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of immunomodulation with galactoside-specific mistletoe lectin on experimental listeriosis.
    Stoffel B, Beuth J, Pulverer G.
    Zentralbl Bakteriol; 1996 Jul 01; 284(2-3):439-42. PubMed ID: 8837402
    [Abstract] [Full Text] [Related]

  • 17. Effects of mistletoe lectin I and ionizing radiation on the glucose and thymidine uptake in tumour cells in vitro.
    Kubasova T, Petcu I, Pfüller U, Köteles GJ.
    Phytother Res; 1999 Dec 01; 13(8):655-9. PubMed ID: 10594933
    [Abstract] [Full Text] [Related]

  • 18. Lectin-induced increase in clonogenic growth of haematopoietic progenitor cells.
    Vehmeyer K, Hajto T, Hostanska K, Könemann S, Löser H, Saller R, Wörmann B.
    Eur J Haematol; 1998 Jan 01; 60(1):16-20. PubMed ID: 9451423
    [Abstract] [Full Text] [Related]

  • 19. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G, Jung ML, Frantz M, Anton R.
    Anticancer Drugs; 1997 Apr 01; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [Abstract] [Full Text] [Related]

  • 20. Activation of c-Jun N-terminal kinase 1 (JNK1) in mistletoe lectin II-induced apoptosis of human myeloleukemic U937 cells.
    Park R, Kim MS, So HS, Jung BH, Moon SR, Chung SY, Ko CB, Kim BR, Chung HT.
    Biochem Pharmacol; 2000 Dec 01; 60(11):1685-91. PubMed ID: 11077051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 621.